ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
106 hedge funds and large institutions have $39.9M invested in Acorda Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 37 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
98% less call options, than puts
Call options by funds: $79K | Put options by funds: $3.77M
Holders
106
Holding in Top 10
–
Calls
$79K
Puts
$3.77M
Top Buyers
| 1 | +$616K | |
| 2 | +$523K | |
| 3 | +$304K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$233K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$168K |
Top Sellers
| 1 | -$2.89M | |
| 2 | -$1.1M | |
| 3 | -$1,000K | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$857K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$603K |